SCN4B and prostate carcinoma: We also assessed the effect of knocking-down the expression of SCN4B, using siRNA, on the invasive properties of cancer cell lines, such as the non-small-cell human lung cancer H460 or the human prostate cancer PC3 cell lines, known to express functional NaV (NaV+) contributing to mesenchymal invasion.